USANA HEALTH SCIENCES INC USNA

About USANA HEALTH SCIENCES INC (USNA): stock profile, AI score and financials

USANA HEALTH SCIENCES INC (USNA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores USNA at 38.9/100 on a composite quality score built from its SEC filings, placing it at rank #2,157 of 2,925 stocks — the bottom half of the AI-ranked universe. USNA scores in the top quartile across institutional flow (77.7). Areas of concern include profitability (23.9) and balance sheet strength (25.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 45.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), USANA HEALTH SCIENCES INC reports quarterly revenue of $223.3M, net income of $-21.4M, an operating margin of -9.0%. USNA trades on the NYSE exchange and files with the SEC under CIK 896264. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate USNA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for USANA HEALTH SCIENCES INC directly from SEC EDGAR.

SEC EDGAR: CIK 896264 →